Valeo Pharma Inc.
VPHIF · OTC
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |
|---|---|---|---|---|
| Market Cap | $12,533 | $53,814 | $58,854 | $53,066 |
| - Cash | $7,502 | $22,501 | $2,043 | $2,836 |
| + Debt | $65,169 | $61,441 | $7,669 | $3,262 |
| Enterprise Value | $70,200 | $92,754 | $64,480 | $53,492 |
| Revenue | $53,910 | $27,745 | $13,557 | $7,470 |
| % Growth | 94.3% | 104.7% | 81.5% | – |
| Gross Profit | $13,077 | $6,281 | $3,955 | $1,381 |
| % Margin | 24.3% | 22.6% | 29.2% | 18.5% |
| EBITDA | -$11,392 | -$16,100 | -$10,975 | -$3,739 |
| % Margin | -21.1% | -58% | -81% | -50.1% |
| Net Income | -$27,808 | -$25,746 | -$14,233 | -$4,761 |
| % Margin | -51.6% | -92.8% | -105% | -63.7% |
| EPS Diluted | -0.32 | -0.32 | -0.2 | -0.082 |
| % Growth | 0% | -60% | -143.3% | – |
| Operating Cash Flow | -$15,695 | -$28,503 | -$12,315 | -$5,298 |
| Capital Expenditures | -$5,553 | -$6,891 | -$3,465 | -$1,405 |
| Free Cash Flow | -$21,248 | -$35,394 | -$15,780 | -$6,703 |